Does Rallies show Form 4 insider transactions for BHC?

Yes. Rallies tracks BHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BHC. It does not provide personalized investment advice.

BHC (Bausch Health Companies Inc) Stock Analysis - Insider Trades

Bausch Health Companies Inc (BHC) is a publicly traded Healthcare sector company. As of May 21, 2026, BHC trades at $5.62 with a market cap of $1.99B and a P/E ratio of 13.20. BHC moved +3.48% today. Year to date, BHC is -25.68%; over the trailing twelve months it is +17.52%. Its 52-week range spans $4.25 to $9.85. Analyst consensus is neutral with an average price target of $7.00. Rallies surfaces BHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BHC stock inside the company?

Recent BHC insider activity includes Lee Frank D. sold 24.46K, Carson Seana sold 4.42K, Carson Seana sold 6.86K, Carson Seana sold 8.39K, and PAULSON & CO. INC. bought 2.50M. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BHC Key Metrics

Key financial metrics for BHC
Metric	Value
Price	$5.62
Market Cap	$1.99B
P/E Ratio	13.20
EPS	$0.42
Dividend Yield	1.00%
52-Week High	$9.85
52-Week Low	$4.25
Volume	8
Avg Volume	0
Revenue (TTM)	$10.27B
Net Income	$120.00M
Gross Margin	0.00%

Recent BHC Insider Trades

Lee Frank D. sold 24.46K (~$132.80K) on May 19, 2026.
Carson Seana sold 4.42K (~$25.50K) on Mar 3, 2026.
Carson Seana sold 6.86K (~$39.63K) on Mar 2, 2026.
Carson Seana sold 8.39K (~$49.91K) on Feb 27, 2026.
PAULSON & CO. INC. bought 2.50M (~$15.63M) on Nov 25, 2025.

Latest BHC News

Bausch Health Q1 Revenues Jump 12% to $2.52B Despite $1.426B Impairment — Apr 29, 2026
Bausch Health Q4 Sales Rise 9% to $2.8B but Posts $112M Loss — Feb 23, 2026
Bausch Health's OraPharma Marks 25 Years of ARESTIN with Canada, Puerto Rico Expansion — Feb 19, 2026
Bausch Health Q4 Revenue Rises 9%, Cash Flow Drops $205M After Red Sea Trial Failure — Feb 19, 2026
Bausch Health Posts 9% Q4 Growth, Cuts $320M Debt, Sets 2026 Targets — Feb 19, 2026

BHC Analyst Consensus

6 analysts cover BHC: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.00.

Common questions about BHC

Who is trading BHC stock inside the company?: Recent BHC insider activity includes Lee Frank D. sold 24.46K, Carson Seana sold 4.42K, Carson Seana sold 6.86K, Carson Seana sold 8.39K, and PAULSON & CO. INC. bought 2.50M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BHC?: Yes. Rallies tracks BHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BHC. It does not provide personalized investment advice.